Loading…
← CockpitCompetitor Analysis › AVAH Aveanna Healthcare Holdings IncOpen in the cockpit ↗

Aveanna Healthcare Holdings IncAVAHCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services

Provider of home health, hospice and private-duty nursing services, focused heavily on pediatric home care.

Momentum strong 62
Mkt cap
$2.37B
US dollars, full cap
Free float
53%
of shares outstanding
$/day
$29.6M
20-day average traded
Fwd P/E
12.2×
forward earnings
ROIC−WACC
+4.0 pp
WACC 11.4%
Hurdle
-3 pp
Req g minus delivered
Next earnings
120 days
18 Mar 2027
Close · USD$10.85
1D-6.9%
1W-17.1%
1M-14.9%
3M-16.4%
6M+41.2%
YTD+32.7%
1Y+26.6%
ATR %5.8%
Beta0.59
52w lowhigh26.3% off high

What Aveanna Healthcare does

Provider of home health, hospice and private-duty nursing services, focused heavily on pediatric home care.

Paid mostly by state Medicaid programs, which set the hourly rates for nursing visits in children's homes, with Medicare paying set amounts for home health and hospice. Results therefore depend on state rate decisions and on how many nurses it can hire and keep. Bain Capital owned it before its 2021 listing.

Products and services

  • Private-duty nursing (pediatric focus)
  • Home health services
  • Hospice care
  • Home medical equipment/solutions

Customers

  • Medically fragile children/adults
  • Medicaid/Medicare beneficiaries
  • Families

Where it sits in the supply chain

  • Health care services
  • Home health & pediatric nursing
  • Private-duty nursing, home health…

What could go right

  • Aging/pediatric home-care demand growth
  • State Medicaid reimbursement rate increases

What could go wrong

  • Nursing labor shortage/wage inflation
  • Medicaid reimbursement rate risk

Moat: narrow (scale, regulatory licence). Largest pediatric private-duty nursing provider in a heavily state-regulated, labor-constrained industry.

Headquarters: Atlanta, Georgia · Founded: 1999 · Employees: 35,500

Named competitors

Aveanna Healthcare at a glance

Size Aveanna Healthcare (AVAH) is a United States Health Care company (Medical/Nursing Services) with a market value of $2.37B, the 1674th largest of 3,085 United States companies the cockpit tracks. Shares closed at $10.85 on 18 Nov 2026.

Performance Over six months the shares gained 41.2%, against +19.1% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 21 in its peer set.

Growth Revenue grew 16.8% over the last twelve months (peer median +4.6%); the operating margin is 12.3% (peer median 7.6%).

Valuation It trades at 12.2× forward earnings against a peer median of 37.6× (cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.0 points above its cost of capital (11.4% WACC).

Short interest Short interest is 3.3% of the free float (30 Oct 2026).

Next results Next results expected around 18 Mar 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026AVAH 141Peer median 120
Six months, rebased to 100: Aveanna Healthcare against the median of its 20 peers (local-currency closes).

Aveanna Healthcare financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$2.68B$2.43B$2.02B$1.90B$1.79B
Revenue growth—+20%+7%+6%—
Gross profit$852M$800M$625M$582M$532M
EBITDA$359M$296M$182M$144M$118M
Net income$306M$225M-$10.9M-$135M-$662M
Free cash flow$198M$115M$24.1M$16.6M-$60.4M
Capital expenditure$9.70M$7.45M$6.32M$6.12M$12.0M
Total debt$1.54B$1.51B$1.50B$1.50B$1.50B

Quarterly statements and history in the cockpit →

Aveanna Healthcare competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%0%+20%MDADUS002044ALIF-BAZTANEOAGARWALEYE603882EMEIS300244VIJAYAPSNLACHCSNDAAMBEALALPATHLABWGSAGLTDOCMCOV-BAVAH6-month return →1-month return →
Up and to the right = strong over both horizons. Aveanna Healthcare is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%25×50×75×MDADUS002044ALIF-BAZTANEOAGARWALEYE603882300244VIJAYAACHCAMBEALALPATHLABWGSAGLMCOV-BAVAHRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Aveanna Healthcare is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%MDADUS002044ALIF-BAZTAAGARWALEYE603882EMEIS300244VIJAYAAMBEALALPATHLABTDOCMCOV-BAVAHGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Aveanna Healthcare is the large dot.

Aveanna Healthcare competitors and peer comparison

Head to head with its named competitors (AVAH vs ADUS vs EHC vs BTSG)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Aveanna Healthcare AVAH$2.37B+41%+17%12%12.2×7.7%
Addus HomeCare ADUS$2.25B+29%+12%11%16.2×4.0%
Encompass Health EHC$13.2B+27%+9%18%20.1×5.7%
BrightSpring Health Services BTSG$13.6B+17%+23%4%28.8×24.9%
Pennant PNTG$1.26B+1%+39%6%23.7×20.7%
Chemed CHE$7.12B+24%+5%14%20.2×3.3%

How Aveanna Healthcare compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Aveanna Healthcare against its 20 peers (data as of 18 Nov 2026)
MeasureAVAHPeer medianRank in peer set
1-month return-14.9%-0.3%2nd lowest of 21
6-month return+41.2%+19.1%5th highest of 21
Distance from 52-week high-26.3%-13.7%8th lowest of 21
Revenue growth (TTM)+16.8%+4.6%5th highest of 21
Operating margin12.3%7.6%4th highest of 21
Forward P/E12.2×37.6×cheapest of 17
Growth the price implies (Req g, 7 yrs)7.7%12.5%8th least demanding of 15
Growth delivered (Del g)+10.2%+10.1%8th highest of 15
Hurdle (Req g minus delivered)-2.5 pp+3.9 pp5th least demanding of 15
ROIC minus cost of capital+4.0 pp-1.6 pp4th highest of 20
EV / EBITDA10.4×12.1×4th cheapest of 14
Net debt / EBITDA3.8×2.2×6th most indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
AddLife ALIF-B.STSweden$2.13B+15%+2%8%39.0×21.1%+14.6%
Azenta AZTAUnited States$2.03B+162%+5%-2%83.2×38.0%+3.9%
NeoGenomics NEOUnited States$1.98B+72%+11%-6%53.5×n/an/a
Dr. Agarwal's Health Care AGARWALEYE.NSIndia$1.86B+20%+26%15%77.1×43.0%+26.9%
Guangzhou Kingmed Diagnostics 603882.SSChina$1.86B+5%-3%7%29.9×5.4%-6.1%
Emeis EMEIS.PAFrance$1.78B-33%+4%3%n/a21.2%+8.5%
Dian Diagnostics 300244.SZChina$1.70B+1%-5%9%21.8×0.3%-1.1%
Vijaya Diagnostic Centre VIJAYA.NSIndia$1.69B+18%+24%32%63.0×40.4%+16.7%
Personalis PSNLUnited States$1.62B+88%+17%-157%n/an/an/a
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
Sonida Senior Living SNDAUnited States$1.59B-11%+70%-8%n/an/an/a
Ambea AMBEA.STSweden$1.59B+28%+11%9%15.2×1.1%+7.7%
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
GeneDx WGSUnited States$1.56B+16%+15%-14%54.2×n/an/a
agilon health AGLUnited States$1.52B+12%+2%-2%34.1×n/an/a
Teladoc Health TDOCUnited States$1.47B+24%-2%-5%n/a-6.4%+18.3%
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%

Questions

Who are Aveanna Healthcare's main competitors?
Named competitors: Amedisys (private or unlisted), Addus HomeCare (ADUS), Encompass Health (EHC), BrightSpring Health Services (BTSG), Enhabit (private or unlisted), Pennant Group (PNTG). The cockpit's measured peer set (industry) also includes Pediatrix Medical (MD), Addus HomeCare (ADUS), Meinian Onehealth Healthcare (002044.SZ), AddLife (ALIF-B.ST), Azenta (AZTA), NeoGenomics (NEO).
Is Aveanna Healthcare expensive compared with its peers?
On forward p/e it trades at 12.2× against a peer median of 37.6×, cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Aveanna Healthcare stock performed?
Over six months to 18 Nov 2026 the shares returned +41.2% against +19.1% for the median peer; over one year +26.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.